1st Total Artificial Heart Patient in Slovenia Discharged from UMC Ljubljana Using the Freedom® Portable Driver
SynCardia Total Artificial Heart was the “Perfect Solution” for Near-Death Patient with Ventricular Septal DefectContinue reading
1st Total Artificial Heart Patient in Slovenia Discharged from UMC Ljubljana Using the Freedom® Portable Driver
SynCardia Total Artificial Heart was the “Perfect Solution” for Near-Death Patient with Ventricular Septal DefectContinue reading
Ceremony Dedicates Arizona Center for Innovation
The Arizona Center for Innovation was dedicated on Jan. 18 in a ceremony at the UA Tech Park.Continue reading
Where Does Your Future Lie? Perhaps In Your Own Backyard!
Find Out through ARIZONA’s SCITECH Festival – January 25–March 14, 2012Continue reading
The Arizona Commerce Authority (ACA) is pleased to announce its second $1.5 million Arizona Innovation Challenge, the country’s largest monetary award for a technology commercialization challenge.Continue reading
AZBio Fast Lane Award Winner and Leading Social Health Company for Women Partners With the Leader in Health Video to Expand Reach for Its Women’s Health Video Continue reading
The development of a new drug is a long, complicated process involving up to 15 years of research and, in many cases, hundreds of millions of dollars. There are two distinct processes that every drug must go through before reaching the general patient population and treating a specific disease – Drug Discovery and Drug Development.Continue reading
Regenesis Biomedical Expands Payor Sources to Increase Patient Access with addition of a new Reimbursement and Health Economics Vice President and Expands Leadership Team and Market Reach with a new COO.Continue reading
Over the last 10 days, I learned a lot about the power of support teams.Continue reading
AZBio partners with LexisNexis and State Net to bring you all the latest updates from Washington DC and around the nation. Check out the latest in the January 16, 2012 edition.Continue reading
Manufacturer of World’s Only Approved Total Artificial Heart Profitable for 1st Time in Company’s 10-Year History
SynCardia Systems, Inc., manufacturer of the world’s only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that in 2011, the company nearly doubled sales for the second straight year, representing a four-fold increase since 2009.Continue reading